IL1B and metabolic dysfunction-associated steatotic liver disease: As reported in Table 1, in the medium derived from the cells treated with exosomes extracted from the plasma of NAFLD patients, a significant increase in the IL-1β levels (** p < 0.001) was observed with respect to the control cells and also with respect to cells treated with the exosomes derived from healthy subjects.